---
granola_id: a7d0b169-1d64-495a-bd3a-a5d14504ef39
title: "Abigail Risse and Emre Karatas"
type: note
created: 2025-06-27T15:49:31.189Z
updated: 2025-07-10T23:18:00.290Z
attendees:
  - arisse@ceritypartners.com
---
### Companies & Opportunities Discussed

- Co-pay solutions
	- Arisse expressed strong interest in co-pay focused solutions
	- Looking for potential design partnerships in this space
	- Nate Mozlik (former CEO of Ribbon) exploring business opportunities in this area

### Healthcare Technology Landscape

- Neurology Space:
	- Discussion of neurology MSO model vs. practice acquisition approach
	- Autonomy’s partnership with Neuronet (largest neurology-focused GPO)
	- Focus areas: MS, Botox, home infusions
- Cell & Gene Therapy:
	- ClearTrust - value-based payments solution for cell/gene therapy
	- Quantile - working on payment mechanisms
	- Challenge: Pharma companies struggling with operationalization

### Potential Distribution Partnerships

- Cerity Partners offering distribution partnerships
	- Can act as “kingmakers” for portfolio companies
	- Opportunity for commercial deals through their fund
	- ZoomLogic mentioned as potential candidate

### Specialty Prior Auth Companies

- Companies of interest to Cerity:
	- Resolabs
	- Squad Health
	- Sama Care (noted previous oncology situation that didn’t materialize)
	- Lamar Health
	- Autonomy (currently neurology-focused, potential for ophthalmology and oncology expansion)

### Action Items

- Follow up regarding co-pay solutions (7-day timeline)
- Connect Nate Mozlik for potential design partnership
- Discuss therapeutic area expansion possibilities with Autonomy
- Share additional information about Tulia
- Further discussion about prior auth opportunities

Chat with meeting transcript: https://notes.granola.ai/d/a7d0b169-1d64-495a-bd3a-a5d14504ef39
